Skip to main content
Equibles

PRUDENTIAL FINANCIAL INC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1137774 NEWARK, NJ
Back to ACAD Full portfolio

Position in ACAD

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$9,237,662
+$608,573 QoQ
Shares Held
365,125
-5.8% QoQ
Ownership
0.212%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#54
of 354 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ACAD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

PRUDENTIAL FINANCIAL INC holds $557,787,882 across 190 Biotechnology names. ACAD ranks #17 (1.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 130,659 $81,471,112
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 133,294 $66,211,127
3 BMRN
Biomarin Pharmaceutical Inc
 392,811 $22,476,644
4 INCY
Incyte Corp
 191,312 $21,687,128
5 CYTK
Cytokinetics Inc
 214,535 $18,276,236
6 LGND
Ligand Pharmaceuticals Inc
 54,623 $17,265,784
7 PTCT
Ptc Therapeutics, Inc.
 185,820 $15,157,337
8 MRVI
Maravai Lifesciences Holdings, Inc.
 2,152,154 $13,429,440

All Filings in ACAD

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,237,662 365,125
2026-03-31 $8,629,089 387,650
2025-12-31 $12,977,854 485,880
2025-09-30 $19,407,022 909,420
2025-06-30 $14,785,738 685,477
2025-03-31 $5,889,922 354,601
2024-12-31 $4,660,184 253,961
2024-06-30 $581,928 35,811
2024-03-31 $19,834,796 1,072,731
2023-12-31 $13,873,961 443,116
2023-09-30 $6,827,517 327,616
2023-06-30 $3,818,252 159,426
2023-03-31 $757,053 40,226
2022-09-30 $282,962 17,296
2022-06-30 $372,412 26,431
2022-03-31 $574,764 23,731
2021-12-31 $230,365 9,870
2021-09-30 $173,740 10,460
2021-06-30 $247,558 10,150
2020-12-31 $2,997,768 56,075
2020-06-30 $10,372 214
2020-03-31 $6,717 159